Israel

Nanox to Announce Third Quarter 2020 Financial and Operating Results on Monday, November 9, 2020

Monday, October 26, 2020 - 12:00pm

NEVE ILAN, Israel, Oct. 26, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announces that it will release its third quarter 2020 financial and operating results for the period ended September 30, 2020 on Monday, November 9, 2020 prior to the start of trading.

Key Points: 
  • NEVE ILAN, Israel, Oct. 26, 2020 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (Nanox or the Company), an innovative medical imaging technology company, announces that it will release its third quarter 2020 financial and operating results for the period ended September 30, 2020 on Monday, November 9, 2020 prior to the start of trading.
  • Management will host a conference call and webcast at 8:30am ET on that day.
  • Nanox, founded by the serial entrepreneur Ran Poliakine, is an Israeli corporation that is developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications.
  • Except as required by law, Nanox undertakes no obligation to update publicly any forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Nanox's expectations.

CollPlant Receives Substantial First Order for its Vergenix™ Flowable Gel Product in Ukraine

Monday, October 26, 2020 - 11:00am

This order is from a new distributor operating in Ukraine, and is in addition to CollPlant's recent announcement regarding a distribution agreement and for a first order for Vergenix FG covering six Commonwealth of Independent States (CIS) countries.

Key Points: 
  • This order is from a new distributor operating in Ukraine, and is in addition to CollPlant's recent announcement regarding a distribution agreement and for a first order for Vergenix FG covering six Commonwealth of Independent States (CIS) countries.
  • Patient population in Ukraine will now have access to VergenixFG, and will benefit from this unique product in their wound healing.
  • We look forward to expanding our distribution network in EU countries," stated CollPlant CEO, Yehiel Tal.
  • CollPlant is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, and medical aesthetics.

Ituran Location and Control Ltd. Schedules Third Quarter 2020 Results Release and Conference Call For Wednesday, November 18, 2020

Monday, October 26, 2020 - 11:00am

AZOUR, Israel, Oct. 26, 2020 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), announced that it will be releasing its third quarter 2020 results on Wednesday, November 18, 2020.

Key Points: 
  • AZOUR, Israel, Oct. 26, 2020 /PRNewswire/ -- Ituran Location and Control Ltd. (NASDAQ: ITRN), announced that it will be releasing its third quarter 2020 results on Wednesday, November 18, 2020.
  • On the call, management will review and discuss the results, and will be available to answer investor questions.
  • To participate, call one of the following teleconferencing numbers.Please begin placing your calls a few minutes before the conference call commences.
  • Established in 1995, Ituran has approximately 3,000 employees worldwide, with offices in Israel, Brazil, Argentina, Mexico, Ecuador, Columbia, India, Canada and the United States.

Protalix BioTherapeutics to Participate in Virtual Investor KOL Roundtable

Monday, October 26, 2020 - 10:50am

The KOL Roundtable is taking place virtually on Tuesday, October27 through Thursday, October29.

Key Points: 
  • The KOL Roundtable is taking place virtually on Tuesday, October27 through Thursday, October29.
  • The Company's Roundtable presentation will be a live video webcast, moderated discussion for up to one hour.
  • received a BA degree in 1966 from the University of California at Berkeley and received his M.D.
  • Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights for taliglucerase alfa, excluding Brazil, where Protalix retains full rights.

New Fortress Energy Invests in Green Hydrogen Production Technology Company H2Pro

Monday, October 26, 2020 - 10:00am

New Fortress Energy Inc. (NASDAQ: NFE) (New Fortress or the Company) announced that it has made an investment in H2Pro, an Israel-based company developing a novel, efficient and low-cost green hydrogen production technology.

Key Points: 
  • New Fortress Energy Inc. (NASDAQ: NFE) (New Fortress or the Company) announced that it has made an investment in H2Pro, an Israel-based company developing a novel, efficient and low-cost green hydrogen production technology.
  • Were excited to partner with H2Pro and invest in a promising technology that can reduce green hydrogen production costs dramatically, said Wes Edens, CEO and Chairman of New Fortress.
  • H2Pro has an innovative, clean and affordable hydrogen production technology called E-TAC (Electrochemical-Thermally Activated Chemical) that uses renewable energy to split water (H2O) into hydrogen and oxygen in two separate phases.
  • About New Fortress Energy Inc.
    New Fortress Energy Inc. (NASDAQ: NFE) is a global energy infrastructure company founded to help accelerate the worlds transition to clean energy.

Rapid Reshore & Development and BrainStorm Cell Therapeutics Announce Agreement to Advance Construction of BrainStorm's U.S. Manufacturing Facility

Monday, October 26, 2020 - 10:00am

BrainStorm seeks to locate, design and construct a new commercial manufacturing facility in the U.S. to prepare for potential commercialization.

Key Points: 
  • BrainStorm seeks to locate, design and construct a new commercial manufacturing facility in the U.S. to prepare for potential commercialization.
  • BrainStorm intends to use the facility primarily for cell therapy production.
  • Site selection analyses will begin immediately with the goal of identifying locations that offer a cost-effective solution for BrainStorm's new manufacturing facility.
  • About BrainStorm Cell Therapeutics Inc.
    BrainStorm Cell Therapeutics Inc.is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases.

Elbit Systems Reports Impact on its Third Quarter 2020 Financial Results Due to COVID-19

Monday, October 26, 2020 - 7:54am

Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended.

Key Points: 
  • Forwardlooking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended.
  • Although the Company believes the expectations reflected in theforward-lookingstatements contained herein are reasonable, it cannot guarantee future results, level of activity, performance or achievements.
  • Elbit Systems Ltd., its logo, brand, product, service and process names appearing in this Press Release are the trademarks or service marks of Elbit Systems Ltd. or its affiliated companies.
  • Reference to or use of a product, service or process other than those of Elbit Systems Ltd. does not imply recommendation, approval, affiliation or sponsorship of that product, service or process by Elbit Systems Ltd.

SuperCom Receives Nasdaq Letter on Minimum Bid Requirements

Friday, October 23, 2020 - 9:30pm

SuperCom expects to regain compliance with the minimum bid price requirement within the upcoming 180 days compliance period.

Key Points: 
  • SuperCom expects to regain compliance with the minimum bid price requirement within the upcoming 180 days compliance period.
  • Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until April 19, 2021, to regain compliance with the minimum bid price requirement.
  • SuperCom expects to regain compliance with the minimum bid price requirement within the compliance period.
  • In the event the Company does not regain compliancebyApril 13, 2021, the Company may be eligible a second 180-calendar day compliance period.

AJC Lauds Announcement of Israel-Sudan Peace Agreement

Friday, October 23, 2020 - 6:56pm

NEW YORK, Oct. 23, 2020 /PRNewswire/ -- American Jewish Committee (AJC) praised the announcement today that Sudan will establish full diplomatic relations with Israel.

Key Points: 
  • NEW YORK, Oct. 23, 2020 /PRNewswire/ -- American Jewish Committee (AJC) praised the announcement today that Sudan will establish full diplomatic relations with Israel.
  • Sudan will become the fifth Arab country to sign a peace agreement with Israel.
  • "Today's announcement is indicative of a very positive trend, a change of heart, among Arab leaders across the region regarding Israel," said AJC CEO David Harris.
  • "In this peacemaking endeavor, Prime Minister Netanyahu's vision and President Trump's dedication to advancing Arab-Israeli peace have been transformative."

ScoutCam Announces Success of HD Micro Video Camera in NASA’s Robotic Refueling Mission 3

Friday, October 23, 2020 - 12:20pm

Custom-developed for NASA between 2015 and 2016, micro ScoutCam 8.0 HD features one module consisting of HD camera and illumination.

Key Points: 
  • Custom-developed for NASA between 2015 and 2016, micro ScoutCam 8.0 HD features one module consisting of HD camera and illumination.
  • The second phase of the Robotic Refueling Mission utilized micro ScoutCam 1.2, the first generation of the companys minuscule video camera.
  • We are thrilled that micro ScoutCam 8.0 HD was a success in NASAs RRM3 mission, said Yaron Silberman, Chief Executive Officer of ScoutCam.
  • In addition to its miniature size, the versatile micro ScoutCam 8.0 HD camera features state of the art customizable optics and noteworthy image quality.